HK1223552B - 用於癌症的組合療法 - Google Patents

用於癌症的組合療法 Download PDF

Info

Publication number
HK1223552B
HK1223552B HK16111827.8A HK16111827A HK1223552B HK 1223552 B HK1223552 B HK 1223552B HK 16111827 A HK16111827 A HK 16111827A HK 1223552 B HK1223552 B HK 1223552B
Authority
HK
Hong Kong
Prior art keywords
compound
antibody
cancer
suitably
administered
Prior art date
Application number
HK16111827.8A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1223552A1 (zh
Inventor
Hoos Axel
W. ORFORD Keith
CHUN Patrick
Sriram Venkataraman
M. PINHEIRO Elaine
W. Ebbinghaus Scot
Original Assignee
Merck Sharp & Dohme Corp.
Novartis Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme Corp., Novartis Pharma Ag filed Critical Merck Sharp & Dohme Corp.
Priority claimed from PCT/US2014/039686 external-priority patent/WO2014193898A1/en
Publication of HK1223552A1 publication Critical patent/HK1223552A1/zh
Publication of HK1223552B publication Critical patent/HK1223552B/zh

Links

HK16111827.8A 2013-05-31 2014-05-28 用於癌症的組合療法 HK1223552B (zh)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361829472P 2013-05-31 2013-05-31
US61/829,472 2013-05-31
US201361873476P 2013-09-04 2013-09-04
US61/873,476 2013-09-04
US201461981906P 2014-04-21 2014-04-21
US61/981,906 2014-04-21
PCT/US2014/039686 WO2014193898A1 (en) 2013-05-31 2014-05-28 Combination therapies for cancer

Publications (2)

Publication Number Publication Date
HK1223552A1 HK1223552A1 (zh) 2017-08-04
HK1223552B true HK1223552B (zh) 2021-07-23

Family

ID=

Similar Documents

Publication Publication Date Title
EP3003316B1 (en) Combination therapies for cancer
EP3560498B1 (en) Combination comprising an mek inhibitor and a b-raf inhibitor
US20160089434A1 (en) Combinations of an anti-pd-l1 antibody and a mek inhibitor and/or a braf inhibitor
AU2013334599B2 (en) Combination
US20160367662A1 (en) Combinations of trametinib, panitumumab and dabrafenib for the treatment of cancer
TW201427667A (zh) 治療和布魯頓（ｂｒｕｔｏｎ’ｓ）酪胺酸激酶相關之疾病或失調的方法
WO2019106605A1 (en) Combination treatment for cancer
HK40081897A (zh) 包含mek抑制剂和b-raf抑制剂的组合
HK40081897B (zh) 包含mek抑制剂和b-raf抑制剂的组合
HK40106558B (zh) 包含mek抑制剂和b-raf抑制剂的组合
HK40011584A (zh) 包含mek抑制剂和b-raf抑制剂的组合
HK40011584B (zh) 包含mek抑制剂和b-raf抑制剂的组合
HK1167287A (zh) 包含mek抑制剂和b-raf抑制剂的组合